Clinical Research Directory
Browse clinical research sites, groups, and studies.
Proactive Risk Evaluation for Cardiac Implantable Electronic Device Strategy Using AI-ECG
Sponsor: National Defense Medical Center, Taiwan
Summary
The goal of this clinical trial is to learn whether an artificial intelligence-enhanced electrocardiogram (AI-ECG) strategy improves timely intervention of patients requiring cardiac implantable electronic devices (CIEDs), compared with standard clinical care.
Official title: Evaluation of an Artificial Intelligence-Enhanced Electrocardiogram Strategy Versus Standard Care to Identify Patients Requiring Cardiac Implantable Electronic Devices: A Randomized Controlled Trial
Key Details
Gender
All
Age Range
65 Years - 90 Years
Study Type
INTERVENTIONAL
Enrollment
11492
Start Date
2025-11-01
Completion Date
2026-10-31
Last Updated
2025-12-12
Healthy Volunteers
No
Conditions
Interventions
AI-ECG driven ECG monitoring
Participants identified as high-risk for CIED implantation by the AI-ECG system will receive a continuous cardiac rhythm monitor for up to 7 days.
Locations (1)
Tri-Service General Hospital
Taipei, Taiwan